Durect Corp (DRRX) Stock: Here’s What You Need To Know

Durect Corp. (NASDAQ:DRRX) On Monday, Durect Corp stock fell by 32% after Pain Therapeutics (PTIE) received a Complete Response Letter — CRL — from the Food and Drug Administration — FDA. The drug that received the CRL is known as Remoxy ER, and was Pain’s drug obtained through a license from Durect Corp. The FDA … Read more

Pain Therapeutics (PTIE) Stock | Where Will It Go Next?

Pain Therapeutics, Inc. (NASDAQ: PTIE) Pain Therapeutics stock has traded relatively flat over the past six months. However, that seems to have changed yesterday. After announcing updates to it’s drug portfolio, investors pushed the stock up more than 50% yesterday. Unfortunately, that momentum simply couldn’t continue as the stock starts to correct today. So today, … Read more

Pain Therapeutics (PTIE) Stock Climbs On Drug Portfolio Update

Pain Therapeutics, Inc. (NASDAQ: PTIE) Pain Therapeutics has traded relatively flat over the past six months; and they’ve been incredibly quiet in the process. However, it seems as though that is starting to change. Today, the stock is spiking up following an update with regard to the company’s portfolio of drug candidates. Today, we’ll talk … Read more